Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Prostatic Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Leukemia 2Colorectal Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Tinnitus 1Squamous NSCLC 1Solid Tumors 1Sinusitis 1Rib Fractures 1Pelvic Pain 1Ovarian Neoplasms 1Ototoxicity 1Non-Muscle Invasive Bladder Neoplasms 1Mycosis Fungoides 1Metrorrhagia 1Menorrhagia 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leiomyoma 1Kidney Neoplasms 1Hearing Loss 1Head and Neck Neoplasms 1Extensive Stage Small Cell Lung Carcinoma 1Deafness 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Metrorrhagia × 30 days × Clear all
NCT05538689 2026-06-05

SOUL

University of Chicago

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡